STOCKHOLM, March 18, 2026 /PRNewswire/ -- Atrogi AB, a clinical stage biotech company pioneering novel GPCR pathway-signalling modulators to transform metabolic and muscle health, today announces that ...
First-in-class oral therapy ATR-258 mimics the effects of exercise – driving fat loss, increasing muscle, and improving metabolism – with broad potential as a novel treatment for muscle-sparing weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results